Intellectual Property

At Medigen, both prophylactic and therapeutic vaccines are designed to instruct patient’s immune system to generate the desired immune responses to prevent and/or treat diseases.

Medigen holds many granted patents and patent applications worldwide for global vaccine applications including influenza, chikungunya, dengue, yellow fever and others. For certain products, Medigen obtained exclusive rights to technologies and materials from the other U.S. organizations.